The post FDA asserts it has regulatory role over CBD products in USA was originally published on HempToday. Subscribe to our newsletter, check out our events and follow us on facebook, instagram and twitter.
The United States Food and Drug Administration (FDA) has asserted its authority to regulate products derived from cannabis, including hemp. FDA Commissioner Scott Gottlieb said CBD products, including those derived from hemp, would be subject to FDA oversight.
The declaration came recently in the wake of December’s signing of the U.S. Farm Bill that expanded the legal bounds for hemp
Gottlieb said in a press release that while the Farm Bill removed hemp from the Controlled Substances Act, the agency still has a regulatory responsibility.
“Congress explicitly preserved the agency’s current authority to regulate products containing cannabis or cannabis-derived compounds under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and section 351 of the Public Health Service Act,” Gottlieb said. “In doing so, Congress recognized the agency’s important public health role with respect to all the products it regulates.”
